arrow
G

Gregory J. Cost

Casebia Therapeutics
H-index:33
Citation Count:1.2万
Views:0

Biography

No content for now.

Education

No content for now.

Work Experience

No content for now.

Honors & Awards

No content for now.

Preclinical efficacy and safety assessment of engineered regulatory T cells for treatment of IPEX and other autoimmune disorders

工程化调节性T细胞治疗IPEX及其他自身免疫性疾病的疗效与安全性评估

2026-03-130
PRE
Integration of therapeutic cargo into the human genome with programmable type V-K CAST

利用可编程V-K型CAST将治疗性载荷整合到人类基因组中

2025-03-131
OA
AFNT-212: A TRAC-knocked-in KRASG12D-specific TCR-T cell product enhanced with CD8αß and a chimeric cytokine receptor for treatment of solid cancers
2024-03-220
PRE
Non-viral engineered T cell therapy specific for the hotspot mutation p53 R175H that integrates signal 1 (TCR), signal 2 ( co-stimulation) and signal 3 (cytokine) and co-opts FasL-dependent apoptosis to achieve a coordinated antitumor CD4/8 T cell response
2024-03-220
PRE
Novel and Engineered Type II CRISPR Systems from Uncultivated Microbes with Broad Genome Editing Capability
2023-06-012
OAAI
Novel CRISPR-Associated Gene-Editing Systems Discovered in Metagenomic Samples Enable Efficient and Specific Genome Engineering
2023-06-014
OAAI
Resolution of hepatic fibrosis after ZFN-mediated gene editing in the PiZ mouse model of human α1-antitrypsin deficiency
2023-03-010
OAAI
Compact Cas9d and HEARO enzymes for genome editing discovered from uncultivated microbes
2022-12-1512
OAAI
Successful knock-in of Hypertrophic Cardiomyopathy-mutation R723G into the MYH7 gene mimics HCM pathology in pigs
2018-03-1933
OAAI
A Genome Edited Pig with the Hypertrophic Cardiomyopathy-Mutation R723G in the MYH7-gene
2018-02-010
OAAI
Towards Clinical Translation of Hematopoietic Stem Cell Gene Editing for the Correction of SCID-X1 Mutations
2016-05-010
OAAI
A NOVEL IN VIVO CHEMOSELECTION STRATEGY FOR GENETICALLY MODIFIED HEMATOPOIETIC STEM CELLS
2015-06-011
PREAI
AAVHSC Vectors Encoding Zinc-Finger Nucleases Mediate Efficient Targeted Integration at the Human AAVS1 Locus in CD34+Human Hematopoietic Stem Cells
2015-05-010
OAAI
Correction of the Sickle-Cell Disease Mutation in Human Hematopoietic Stem/Progenitor Cells
2015-05-010
OAAI
Gene Correction of IL2RG in Human Hematopoietic Stem and Progenitor Cells
2015-05-010
OAAI
Genome Editing-Enabled HIS Assays Expand Drug Target Pathways for Charcot-Marie-Tooth Disease
2014-09-1633
OAAI
Efficient gene targeting by homology-directed repair in rat zygotes using TALE nucleases
2014-07-0245
OAAI
Human Intestinal Tissue with Adult Stem Cell Properties Derived from Pluripotent Stem Cells (vol 2, pg 838, 2014)
2014-07-011
OAAI
Human Intestinal Tissue with Adult Stem Cell Properties Derived from Pluripotent Stem Cells
2014-06-0180
OAAI